- Home
- NDRA vs VCIG Comparison
NDRA vs VCIG Comparison
Compare NDRA & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NDRA | VCIG |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.3M |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NDRA | VCIG |
|---|---|---|
| Price | $5.12 | $0.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | 114.8K | ★ 3.2M |
| Earning Date | 11-17-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | N/A | ★ $32,903,041.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.88 |
| Revenue Growth | N/A | ★ 24.77 |
| 52 Week Low | $2.90 | $0.80 |
| 52 Week High | $11.96 | $1,344.00 |
Technical Indicators
Market Signals| Indicator | NDRA | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 31.38 |
| Support Level | $5.17 | $0.89 |
| Resistance Level | $6.00 | $1.28 |
| Average True Range (ATR) | 0.64 | 0.13 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 25.74 | 0.53 |
Price Performance
Historical ComparisonAbout NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.